Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities (Q36776253)
Jump to navigation
Jump to search
scientific article published on 11 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities |
scientific article published on 11 July 2012 |
Statements
Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities (English)
M Ren
H Qin